Exercise During Pregnancy: Effects on the Maternal-Fetal Unit
PREGFIT
Benefits of Exercise for the Maternal-Fetal Unit During Pregnancy
1 other identifier
interventional
64
1 country
1
Brief Summary
Metabolic alterations during pregnancy have been associated with adverse maternal-fetal outcomes, including low birth weight and pregnancy complications. Maternal endothelial dysfunction, oxidative stress, insulin resistance, and placental mitochondrial dysfunction are thought to contribute to fetal metabolic disturbances. Lifestyle changes, such as structured exercise during pregnancy, may modulate maternal and placental factors. This randomized controlled trial will evaluate the effects of a multicomponent exercise program during the second and third trimester on maternal functional capacity, vascular health, anthropometry, metabolic biomarkers, placental function, and newborn health outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pregnancy
Started Sep 2025
Typical duration for not_applicable pregnancy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 23, 2025
CompletedFirst Posted
Study publicly available on registry
December 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 20, 2027
December 4, 2025
December 1, 2025
2.3 years
September 23, 2025
December 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cardiorespiratory fitness (Vo2max)
The modified cycle protocol will be performed to estimate maximal oxygen uptake (VO2max), and will be used as measure of cardiorespiratory fitness.
at the 16th and 34-36th week of gestation
Maternal weight gain (kg)
Maternal weight gain will be defined as the weight change from baseline measurement to the last measurement
34-36th week of gestation
Secondary Outcomes (40)
Systolic and diastolic blood pressure (mmHg)
at the 16th and 34-36th week of gestation
Resting heart rate (bpm)
at the 16th and 34-36th week of gestation
Muscle strength (kg)
at the 16th and 34-36th week of gestation
Whole bone mineral density (g/cm2)
at the 16th to 34-36th week of gestation
Fat free mass
at the 16th to 34-36th week of gestation
- +35 more secondary outcomes
Other Outcomes (2)
Placental mitochondrial leak respiration
At delivery
Changes to maternal, placenta and umbilical cord proteome
At delivery
Study Arms (2)
Exercise training
EXPERIMENTALParticipants will perform a supervised aerobic exercise program at 70% of maximum heart rate (HRmax), for 45 minutes per session, 3 times per week, during 12 weeks. Each session will follow a standardized protocol: 10 minutes of warm-up, 30 minutes of aerobic exercise, 5 minutes of cool-down and stretching. In addition, strength training sessions will be included 1-2 times per week. All exercise sessions will be delivered by qualified professionals, including exercise specialists, nutritionists, and physiotherapists with \>3 years of experience and a master's-level education in the field. The intervention will be conducted at the Exercise Physiology Unit (E-FIT Group Laboratory), Navarrabiomed Research Center, Pamplona, Spain.
Control
NO INTERVENTIONUsual care as provided by the health services in Spain. The investigators will not advice the women to be inactive.
Interventions
Eligibility Criteria
You may qualify if:
- Primigravid women
- Gestational age 16-20 weeks
- No severe malformations on ultrasound
- Regular prenatal care and medical clearance from obstetrician
- Being healthy and able to exercise following American College of Obstetricians and Gynecologists (ACOG) guidelines
You may not qualify if:
- Medical or obstetric complication excluding exercise ( ACOG guideline) Major surgery or trauma in past year
- Cancer diagnosis
- Cervical incompetence
- History of ≥2 spontaneous abortions
- Multiple pregnancy
- Vaginal bleeding, placenta previa, or threatened abortion
- COPD, asthma, or chronic bronchitis
- Renal, musculoskeletal, cardiovascular, or systemic infections limiting exercise
- Polyhydramnios or oligohydramnios
- Not availability to attend to the physical exercise program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad Pública de Navarralead
- Fundación Instituto de Investigación Sanitaria de Navarracollaborator
- NavarraBiomed Biomedical Research Centercollaborator
- Complejo Hospitalario de Navarracollaborator
Study Sites (1)
Navarrabiomed, Hospital Universitario de Navarra (HUN) and Universidad Pública de Navarra (UPNA)
Pamplona, Navarre, 31010, Spain
Related Publications (3)
Ramirez-Velez R, Aguilar de Plata AC, Escudero MM, Echeverry I, Ortega JG, Salazar B, Rey JJ, Hormiga C, Lopez-Jaramillo P. Influence of regular aerobic exercise on endothelium-dependent vasodilation and cardiorespiratory fitness in pregnant women. J Obstet Gynaecol Res. 2011 Nov;37(11):1601-8. doi: 10.1111/j.1447-0756.2011.01582.x. Epub 2011 Jul 6.
PMID: 21733037RESULTRamirez-Velez R, Lobelo F, Aguilar-de Plata AC, Izquierdo M, Garcia-Hermoso A. Exercise during pregnancy on maternal lipids: a secondary analysis of randomized controlled trial. BMC Pregnancy Childbirth. 2017 Nov 28;17(1):396. doi: 10.1186/s12884-017-1571-6.
PMID: 29179683RESULTPinzon DC, Zamora K, Martinez JH, Florez-Lopez ME, de Plata AC, Mosquera M, Ramirez-Velez R. Type of delivery and gestational age is not affected by pregnant Latin-American women engaging in vigorous exercise: a secondary analysis of data from a controlled randomized trial. Rev Salud Publica (Bogota). 2012 Oct;14(5):731-43.
PMID: 24652353RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 23, 2025
First Posted
December 4, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
December 15, 2027
Study Completion (Estimated)
December 20, 2027
Last Updated
December 4, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
This section provides details of the study plan, including how the study is designed and what the study is measuring.